Axon Enterprise, Inc $AXON Stock Bought by Foguth Wealth Management LLC.

Foguth Wealth Management LLC. grew its position in Axon Enterprise, Inc (NASDAQ:AXON) by 523.4% during the 3rd quarter, Holdings Channel reports. The firm owned 8,005 shares of the biotechnology company’s stock after purchasing an additional 6,721 shares during the quarter. Foguth Wealth Management LLC.’s holdings in Axon Enterprise were worth $3,382,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Clark Wealth Partners increased its position in shares of Axon Enterprise by 25,575.0% during the 3rd quarter. Clark Wealth Partners now owns 2,054 shares of the biotechnology company’s stock worth $868,000 after purchasing an additional 2,046 shares in the last quarter. Signature Resources Capital Management LLC lifted its holdings in Axon Enterprise by 11.5% during the 3rd quarter. Signature Resources Capital Management LLC now owns 670 shares of the biotechnology company’s stock valued at $283,000 after purchasing an additional 69 shares during the last quarter. Onyx Bridge Wealth Group LLC acquired a new position in Axon Enterprise in the third quarter valued at about $369,000. SteelPeak Wealth LLC boosted its position in Axon Enterprise by 35,664.2% in the third quarter. SteelPeak Wealth LLC now owns 238,547 shares of the biotechnology company’s stock valued at $100,791,000 after buying an additional 237,880 shares in the last quarter. Finally, IFP Advisors Inc boosted its position in Axon Enterprise by 10,268.4% in the third quarter. IFP Advisors Inc now owns 169,213 shares of the biotechnology company’s stock valued at $71,496,000 after buying an additional 167,581 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Piper Sandler raised their price objective on shares of Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research note on Tuesday, October 13th. UBS Group boosted their target price on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Citigroup reissued a “market outperform” rating on shares of Axon Enterprise in a report on Thursday, September 17th. Finally, Raymond James Financial set a $675.00 price target on Axon Enterprise in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $718.47.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock traded down $6.37 during trading on Monday, reaching $383.93. The company’s stock had a trading volume of 607,698 shares, compared to its average volume of 1,049,496. The stock has a 50-day moving average price of $501.59 and a two-hundred day moving average price of $474.85. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $764.02. The stock has a market capitalization of $31.19 billion, a P/E ratio of 159.68, a price-to-earnings-growth ratio of 7.34 and a beta of 1.44.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same quarter in the prior year, the firm earned $2.12 EPS. The company’s revenue was up 35.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Axon Enterprise, Inc will post 2.12 EPS for the current fiscal year.

Insider Activity at Axon Enterprise

In other news, insider Isaiah Fields sold 1,017 shares of the stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the sale, the insider directly owned 56,264 shares of the company’s stock, valued at $27,032,038.80. This represents a 1.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the firm’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. This represents a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 47,397 shares of company stock valued at $26,722,984. Insiders own 4.20% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.